$150,780,000
to TRUSTEES OF BOSTON UNIVERSITY
CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Funds CARB-X accelerator program to develop new antibacterial drugs and combat antibiotic resistance.
Addresses critical public health threat of antibiotic-resistant bacteria, essential for pandemic preparedness and national biosecurity.
Stimulates pharmaceutical R&D pipeline and biotech manufacturing capacity for novel antimicrobial compounds.
U.S. investment in antibiotic innovation reduces dependence on foreign pharmaceutical supply chains vulnerable to geopolitical disruption.
Generated by award_classification v1.0.0 via claude-haiku-4-5-20251001 on 2026-05-14. Cost: $0.001334.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75A50122C00028_7505_-NONE-_-NONE-.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.